ABBV

ABBV Biotechnology BMY MRK Uncategorized

AbbVie files lawsuit over selection of Botox for Medicare price negotiations

Feb 12, 2026

ABBV Biotechnology Uncategorized

AbbVie nears five-month low as Humira drives Q4 beat, not Rinvoq

Feb 4, 2026

ABBV Biotechnology Uncategorized

AbbVie posts Q4 beat as Humira outperforms

Feb 4, 2026

ABBV Biotechnology Uncategorized

AbbVie Non-GAAP EPS of $2.71 beats by $0.06, revenue of $16.62B beats by $200M

Feb 4, 2026

abbvie-q4-preview:-here’s-what-to-expect

ABBV Biotechnology JNJ Uncategorized

AbbVie Q4 Preview: Here’s what to expect

Feb 3, 2026

Earnings News Comments hapabapa AbbVie (ABBV) is expected to report a 23% surge in its...

genmab-down-after-trial-data-for-abbvie-partnered-epkinly-in-b-cell-lymphoma

ABBV Biotechnology GMAB Uncategorized

Genmab down after trial data for AbbVie-partnered Epkinly in B-cell lymphoma

Jan 16, 2026

On the Move Comment (1) koto_feja/iStock via Getty Images Genmab (GMAB) on Friday announced that...

abbvie-secures-tariff-relief-in-drug-pricing-deal,-pledges-$100b-investment

ABBV AMGN AZN Biotechnology BMY GILD LLY MRK NVO PFE Uncategorized

AbbVie secures tariff relief in drug pricing deal, pledges $100B investment

Jan 13, 2026

Comments (22) vzphotos/iStock Editorial via Getty Images AbbVie (ABBV) has reached a three-year deal with...

ABBV Biotechnology Uncategorized WST

AbbVie to buy Arizona manufacturing facility from West Pharmaceutical

Jan 12, 2026

merck-in-talks-to-acquire-revolution-medicines-for-about-$30b-–-wsj

ABBV Biotechnology MRK RVMD Uncategorized

Merck in talks to acquire Revolution Medicines for about $30B – WSJ

Jan 9, 2026

On the Move M&A Comments (18) Marko Georgiev/Getty Images News Merck (MRK) is in talks...

ABBV Biotechnology MRK RVMD Uncategorized

Revolution Medicines soars on report Merck in talks to buy (update)

Jan 8, 2026

« Previous Page — Next Page »